Michael Aronstein Net Worth & Insider Trades

Michael Aronstein - Director, Angiogenex, Inc

As of February 4, 2019

What is Michael Aronstein's Net Worth?

The current estimated net worth of Angiogenex, Inc's Director, Michael Aronstein, is estimated to be about $700 . Michael Aronstein owns about 5,500,000 units of Angiogenex, Inc common stock. Recently at Angiogenex, Inc, Michael Aronstein has sold an estimated value of $0 worth.

What is Michael Aronstein's Past Insider Trading?

Michael Aronstein's largest purchase order was 1,000,000 units , worth over $200K on February 4, 2019. In total, Michael Aronstein has made about 1 transaction recently at Angiogenex, Inc. Michael Aronstein usually trades in February, with the busiest year in 2019.

MICHAEL ARONSTEIN

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Michael Aronstein's Salary in 2018?

As Director of Angiogenex, Inc, Michael Aronstein has a total base salary of $0 . The vast majority of their compensation came in the form of stock awards of $0 , option awards of $0 , and other earnings, plans or compensations of $0 .

What is Michael Aronstein's' Mailing Address?

  • Mailing address is 3 Purchase Lane Rye NY 10580 NY

Angiogenex, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Robert Benezra, PRES, CEO, CSO 2018 $0 $0 $0 $0 $0
Michael Strage, VP, COO 2018 $0 $0 $0 $0 $0
Martin Murray, CFO 2018 $0 $0 $0 $0 $0
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1085596/000146970919000046/aggxsch14a_040119apg.htm

What are Angiogenex, Inc's Past Insider Trades?

Angiogenex, Inc's most recent insider trade came on February 4, 2019 by Michael Aronstein who bought 1,000,000 units worth $200K . In the years Angiogenex, Inc was active, insiders at Angiogenex, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in February, with the busiest year in 2019. The most active traders at the company are and Michael Aronstein, Director .

AngioGenex, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1